MRK
Merck & Company Inc
Merck & Company Inc historical holders
total: 18
Jensen Investment Management Merck & Company Inc transactions over time
- Total transactions:
- 7
- New positions:
- 3
- Sold out:
- 3
- Reduced:
- 1
- Held since:
- 2016 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2016 Q3
Eric H. Schoenstein has been an institutional investor in Merck & Company Inc (MRK) since 2015 Q1. According to 2026 Q1 report, Eric H. Schoenstein doesn't hold any shares. The fund/company first acquired MRK in 2015 Q1, initially purchasing 9,530 shares. Eric H. Schoenstein later completely sold out the position and reinvested in MRK again in 2016 Q1. Since the initial investment, Jensen Investment Management has made 6 more transactions in this position.
When did Eric H. Schoenstein exit their MRK position?
Eric H. Schoenstein no longer holds Merck & Company Inc (MRK). They sold off their entire position in 2016 Q3, closing out an investment that began in 2015 Q1.
When did Eric H. Schoenstein first invest in MRK?
Eric H. Schoenstein first invested in Merck & Company Inc (MRK) in 2015 Q1 at the reported quarter-end price of $57.50 per share, acquiring 9,530 shares in their initial purchase.
What is Eric H. Schoenstein's average cost basis for MRK?
Based on historical transaction data, Eric H. Schoenstein's estimated cost basis for Merck & Company Inc (MRK) is approximately $52.93 per share. This represents their average reported price* across all buy transactions.
Has Eric H. Schoenstein reinvested in MRK after selling?
Yes, Eric H. Schoenstein has shown renewed interest in Merck & Company Inc (MRK). After completely selling their position, they reinitiated an investment in 2016 Q1, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $52.93
- Weighted AVG sell price:
- $57.67
MRK transactions history by Jensen Investment Management
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2016 Q3
|
0.00%
|
$57.67
|
-100% (-7,560)
|
|||
|
2016 Q2
|
0.01%
|
$57.67
|
-3.82% (-300)
|
|||
|
2016 Q1
|
0.01%
|
$52.93
|
new
|
|||
|
2015 Q4
|
0.00%
|
$49.39
|
-100% (-7,370)
|
|||
|
2015 Q3
|
0.01%
|
$49.39
|
new
|
|||
|
2015 Q2
|
0.00%
|
$57.50
|
-100% (-9,530)
|
|||
|
2015 Q1
|
0.01%
|
$57.50
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.